While these therapeutic approaches have significantly improved outcomes among people with type 1 diabetes and CKD, this population remains at substantial elevated risk for adverse kidney and cardiovascular events, with limited improvements over the last few decades
A triple agonist is a compound that activates three receptor systems: GLP-1, GIP, and glucagon receptors
Weight loss medication may not be right for everyone, and it's best to carefully review your medical history to determine if a GLP-1 injectable will be safe and effective for you to take
In our study, the majority of the patients with pre-diabetes experienced normal blood sugar levels when they continued their treatment, said Dr
We dont require subscriptions, memberships, or any commitments, and youll never see hidden fees